Fundraising Fox

Patricia Laplante

Investor

Principal at AmorChem

About

Patricia Laplante is a Principal at AmorChem, where she develops and manages technical maturation plans for the firm's drug discovery projects and supports academic research teams moving into drug discovery. She joined AmorChem in 2013 as a Project Manager and later became Director, Project Management, having previously spent 11 years in drug discovery at AstraZeneca R&D Montreal along with roles at Procyon BioPharma and McGill University. She holds an MSc in neurology and neurosurgery from McGill University.

Invests in

Biotech

Investments

Investor

SemaThera

Per the firm's website.

Colleagues at AmorChem